LinkOPH

Speaking at the Retina 2016 meeting, Sophie J. Bakri, MD, explores the question of whether patients who do not respond to anti-VEGF therapy for age-related macular degeneration are truly nonresponders or whether for these patients it is time to “revisi…

Read more →

Johns Hopkins Medicine announced the opening of the Johns Hopkins Zika Center, led by the Wilmer Eye Institute, according to a press release.“Our goal is to care not only for children but also for the whole family and patients of all ages with Zika virus,” William N. May, MD, associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute, said in the release. “Patients will be able to see physicians and staff members from various areas of expertise within our institution, including our school of public health. This breadth (Read more...)

Outcomes following cataract surgery with greater than 90% of patients within 0.5 D of the target spheroequivalent refraction are achieved by less than 1% of surgeons. I give these surgeons an “A” for their results, just like in school. “B” surgeons are 80% to 89%, “C” surgeons from 70% to 79%, “D” surgeons from 60% to 69%, and if you are less than 60%, you are failing. An “A” surgeon uses optical biometry and re-measures axial lengths, usually with immersion, if the eyes differ by more than 0.3 mm or (Read more...)